Skip to main content
SpringerLink
Log in

Interventions cost effective for HIV prevention in PWID

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2015 US dollars

  2. 2015 US dollars

Reference

  • Bernard CL, et al. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis. PLOS Medicine : 24 May 2017. Available from: URL: https://doi.org/10.1371/journal.pmed.1002312

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Interventions cost effective for HIV prevention in PWID. PharmacoEcon Outcomes News 782, 22 (2017). https://doi.org/10.1007/s40274-017-4153-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4153-y

Search

Navigation